Fentanyl Buccal Tablets for Breakthrough Pain in Highly Tolerant Cancer Patients: Preliminary Data on the Proportionality Between Breakthrough Pain Dose and Background Dose
نویسندگان
چکیده
منابع مشابه
Single-dose fentanyl sublingual spray for breakthrough cancer pain
Breakthrough cancer pain (BTCP) is defined as a transient exacerbation of pain that arises in patients with otherwise controlled persistent pain. BTCP typically has a rapid onset and relatively short duration, but it causes a significant amount of physical and psychological distress for patients. Several rapid-onset fentanyl formulations have been introduced in the USA to replace traditional or...
متن کاملFentanyl Sublingual Spray for Breakthrough Pain in Cancer Patients
Breakthrough pain is a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain. Typically, breakthrough pain has a fast onset and short duration, and a significant impact on patients' quality of life. Normal-release oral opioids are the traditional phar...
متن کاملProphylactic Use of Fentanyl Buccal Tablets for Predictable Breakthrough Pain: A Case Report
Short acting opioids, such as morphine, are recommended for the management of predictable breakthrough pain in cancer patients. However, it has been reported that prophylactic fentanyl rescue medication, which is more effective and has a shorter duration of action, is more suitable for some patients depending on their symptoms and the characteristics of their breakthrough pain. Herein, we repor...
متن کاملTreatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management.
BACKGROUND Opioids can be a safe and effective option for carefully selected patients with a structured treatment program that includes consistent monitoring. However, the benefits and risks of opioid therapy for patients with chronic pain, and society as a whole, have been sharply debated. A key component of this debate has involved the administration of rapid-onset opioids for the management ...
متن کاملIntranasal Fentanyl for Breakthrough pain control
Breakthrough pain (BTP) is experienced by approximately 65% of children and adults with chronic pain. Undiagnosed or untreated BTP produces negative emotional, physical, and economic consequences. BTP episodes have a rapid onset and short duration. Short acting oral opioids are the cornerstone of BTP management. Oral medications available to treat BTP episodes like immediaterelease morphine or ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pain and Symptom Management
سال: 2011
ISSN: 0885-3924
DOI: 10.1016/j.jpainsymman.2010.12.010